Neuralink patient table

Every publicly known Neuralink patient across the PRIME, VOICE, and CONVOY studies. Click any column header to sort. An asterisk (*) marks a detail that is likely but not yet confirmed.

Patient #
Name
Hospital
Location
Diagnosis
Study
1
Noland Arbaugh
Barrow Neurological Institute
Phoenix, Arizona, USA
SCI
PRIME
2
Alex Conley
Barrow Neurological Institute
Phoenix, Arizona, USA
SCI
PRIME / CONVOY
3
Brad Smith
Barrow Neurological Institute
Phoenix, Arizona, USA
ALS
PRIME
4
Mike Melgarejo
Barrow Neurological Institute
Phoenix, Arizona, USA
ALS
PRIME
5
RJ Tanner
University of Miami Health
Miami, Florida, USA
SCI
PRIME / CONVOY
6
Rob Greiner
Barrow Neurological Institute
Phoenix, Arizona, USA
SCI
PRIME
7
Jake Schneider
Barrow Neurological Institute
Phoenix, Arizona, USA
ALS
PRIME / CONVOY
8
Nick Wray
University of Miami Health
Miami, Florida, USA
ALS
PRIME / CONVOY
9
Audrey Crews
University of Miami Health
Miami, Florida, USA
SCI
PRIME
10
Not yet public
Barrow Neurological Institute
Phoenix, Arizona, USA
—
PRIME
11
Not yet public
University Health Network
Toronto, Ontario, Canada
—
PRIME
12
Not yet public
University Health Network
Toronto, Ontario, Canada
—
PRIME
13
Paul
University College London Hospitals
London, UK
Motor Neurone Disease (ALS)
PRIME
14
Not yet public
—
—
—
—
15
Not yet public
—
—
—
—
16
Not yet public
—
—
—
—
17
Not yet public
—
UK
Locked-In
PRIME
18
Jon Noble
University College London Hospitals
London, UK
SCI
PRIME
19
Sebastian Gomez-Peña
University College London Hospitals
UK
SCI
PRIME
20
Eoin Egan
University College London Hospitals (Queen Square)
London, UK
Motor Neurone Disease (ALS)
PRIME
21
Kenneth Shock
UT Southwestern
Dallas, Texas, USA
ALS
VOICE
22
Zach McManus
Barrow Neurological Institute
Phoenix, Arizona, USA
ALS
PRIME
23
“LeBrain James”
—
—
—
—
24
CJ Johnson
University of Miami Health
Miami, Florida, USA
SCI
PRIME
25
Terence Mandable
UT Southwestern
Dallas, Texas, USA
Bulbar-onset ALS
VOICE
26
Lee Marten
University Health Network
Toronto, Ontario, Canada
ALS
PRIME
27
Not yet public
—
—
—
—

* Likely, but not yet confirmed by Neuralink, the patient, or the trial site.

Source: Neura Pod patient tracking. Last synced October 2026.